IABP In AMI Patients With SCAI-B Study

NANot yet recruitingINTERVENTIONAL

Enrollment

512

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions

Myocardial Infarction, AcuteCardiogenic Shock

Interventions

DEVICE

IABP (Intra-aortic balloon pump ) implantation

Eligible AMI patients in SCAI-B stage will receive IABP implantation from the femoral artery

Trial Locations (1)

Renmin hospital of Wuhan university, Wuhan

All Listed Sponsors

lead

Renmin Hospital of Wuhan University

OTHER

NCT04989777 - IABP In AMI Patients With SCAI-B Study | Biotech Hunter | Biotech Hunter